Alternative drug purchasing arrangements do not justify raising the prices Medicaid pays for brand drugs

3 April 2020 - As the prescription drug pipeline fills with very high-cost gene therapies and specialty drugs, affordability and access ...

Read more →

1 April 2020 price disclosure confirmed prices

31 March 2020 - Confirmed 1 April 2020 prices resulting from the 2020 April cycle of price disclosure have been published ...

Read more →

National health expenditure projections, 2019–28: expected rebound in prices drives rising spending growth

24 March 2020 - US national health expenditures are projected to grow at an average annual rate of 5.4% for ...

Read more →

Intra-Cellular prices schizophrenia drug at $1,320 per month

23 March 2020 - Intra-Cellular Therapies said on Monday its lead drug to treat schizophrenia was now available at U.S. ...

Read more →

Determinants of orphan drug prices in Germany

21 March 2020 - Legislation introduced in 2011 in Germany has instituted an early benefit assessment of newly licensed pharmaceuticals with ...

Read more →

U.S. pharma that makes potential coronavirus drug touted by Donald Trump doubled price to $19.88 a pill

20 March 2020 - Company calls hike in January during China outbreak coincidental and said it restored old price. ...

Read more →

Low prices won't keep new medicines out of Canada

19 March 2020 - There is no evidence of a link between pricing, research and development, and access to medicine. ...

Read more →

Erlotinib new exchange groups

13 March 2020 - As of April, erlotinib is included as an exchange group on the list of goods for ...

Read more →

Mending the broken social contract for pharmaceutical pricing and innovation

13 March 2020 - The biopharmaceutical industry is under unprecedented assault by the public and politicians.  ...

Read more →

White House principles for reducing drug costs

10 March 2020 - In our partisan times, an opportunity for lawmakers to work across the aisle and get something done. ...

Read more →

Price controls imposed by shortsighted politicians keep new life-saving drugs out

5 March 2020 - Politicians need to step outside the Ottawa bubble and understand how their policies impact the lives of ...

Read more →

The U.S. has a problem with prescription drug prices. Canada shouldn’t try to fix it.

2 March 2020 - President Donald Trump and the U.S. Congress are scrambling to find ways to make medicines more ...

Read more →

Sanofi, fighting back in insulin price debate, says its net prices fell 11%

4 March 2020 - Politicians have called price increases egregious, while large insulin makers have become prime targets for criticism in ...

Read more →

Drug shortages in the United States. Are some prices too low?

3 March 2020 - The US public identified lowering prescription drug prices as the top health priority for Congress in 2019.  ...

Read more →

Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018

3 March 2020 - Using 2007-2018 net pricing data on branded pharmaceutical products in the US, list prices increased by 159% ...

Read more →